UNIGE document Scientific Article
previous document  unige:24932  next document
add to browser collection

Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans

Brezault, Catherine
Delucinge-Vivier, Céline
Dousset, Bertand
show hidden authors show all authors [1 - 9]
Published in Molecular cancer therapeutics. 2011, vol. 10, no. 4, p. 687-96
Abstract Sinusoidal obstruction syndrome (SOS; formerly veno-occlusive disease) is a well-established complication of hematopoietic stem cell transplantation, pyrrolizidine alkaloid intoxication, and widely used chemotherapeutic agents such as oxaliplatin. It is associated with substantial morbidity and mortality. Pathogenesis of SOS in humans is poorly understood. To explore its molecular mechanisms, we used Affymetrix U133 Plus 2.0 microarrays to investigate the gene expression profile of 11 human livers with oxaliplatin-related SOS and compared it to 12 matched controls. Hierarchical clustering analysis showed that profiles from SOS and controls formed distinct clusters. To identify functional networks and gene ontologies, data were analyzed by the Ingenuity Pathway Analysis Tool. A total of 913 genes were differentially expressed in SOS: 613 being upregulated and 300 downregulated. Reverse transcriptase-PCR results showed excellent concordance with microarray data. Pathway analysis showed major gene upregulation in six pathways in SOS compared with controls: acute phase response (notably interleukin 6), coagulation system (Serpine1, THBD, and VWF), hepatic fibrosis/hepatic stellate cell activation (COL3a1, COL3a2, PDGF-A, TIMP1, and MMP2), and oxidative stress. Angiogenic factors (VEGF-C) and hypoxic factors (HIF1A) were upregulated. The most significant increase was seen in CCL20 mRNA. In conclusion, oxaliplatin-related SOS can be readily distinguished according to morphologic characteristics but also by a molecular signature. Global gene analysis provides new insights into mechanisms underlying chemotherapy-related hepatotoxicity in humans and potential targets relating to its diagnosis, prevention, and treatment. Activation of VEGF and coagulation (vWF) pathways could partially explain at a molecular level the clinical observations that bevacizumab and aspirin have a preventive effect in SOS.
Keywords Chemokine CCL20/genetics/metabolismCluster AnalysisGene Expression ProfilingHepatic Veno-Occlusive Disease/chemically induced/geneticsHumansHypoxia-Inducible Factor 1, alpha Subunit/genetics/metabolismImmunohistochemistryLiver/metabolism/pathologyMicroarray AnalysisOrganoplatinum CompoundsReverse Transcriptase Polymerase Chain ReactionSignal Transduction/geneticsVascular Endothelial Growth Factor C/genetics/metabolism
PMID: 21330458
Full text
Article (Published version) (1.5 MB) - public document Free access
Research groups Hépatologie chirurgicale (327)
Métastases du foie (657)
(ISO format)
RUBBIA-BRANDT, Laura et al. Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans. In: Molecular cancer therapeutics, 2011, vol. 10, n° 4, p. 687-96. doi: 10.1158/1535-7163.MCT-10-1072 https://archive-ouverte.unige.ch/unige:24932

527 hits



Deposited on : 2013-01-03

Export document
Format :
Citation style :